Trump Issues Executive Order On Vaccines, Makes Multiple False Claims

Trump signed an executive order to reshape the childhood vaccine schedule. He made multiple false claims, including repeating the debunked vaccines and autism link.

Two Deaths In China Reopen Gene Therapy Debates

Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial oversight, safety reporting, and transparency as gene therapy advances worldwide.

2 Deaths In China Reopen Gene Therapy Debates

Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial oversight, safety reporting, and transparency as gene therapy advances worldwide.

340B Program Changes Could Shift Prescribing Towards Lower Cost Biosimilars

Hospitals often earn large spreads on high-volume branded drugs bought via 340B. Reforms may make hospitals more price-sensitive, raisin uptake of lower-cost biosimilars.

Bill Moves Forward To Cap Insulin Costs And Curb Patent Abuses

Proposed bills could directly lead to lowering patient out-of-pocket costs for items like insulin. Others may indirectly impact costs by curbing possible patent abuses,

A New Approach For Difficult Cancers

Setidegrasib, a first-in-class KRAS G12D degrader, uses the cell’s own recycling system to destroy a key cancer driver instead of merely blocking it.

A Coffee A Day Keeps The Doctor Away?

Large reviews show that one to three cups of brewed coffee a day are linked with lower risks of liver disease, heart disease, stroke and Type 2 diabetes in most adults.

As Numbers Of Abortions Rise, Neverending Mifepristone Fight Heats Up

The abortion pill mifepristone remains embroiled in U.S. legal, political and regulatory battles, despite the Supreme Court temporarily restoring mail access.

Senate Democrats Release Memo On Reforms To Make Health Insurance More Affordable

The debate between Medicare for All and Medicare by Choice advocates, both of whom seek better affordability, is shaping up to be an interesting one in the coming years.

A New Way To Understand Who We Are

Blended genome–exome sequencing reads key regions deeply and the rest of the genome shallowly, cutting costs and ancestry bias while preserving genetic insight.